2m 2m 2m 2m 2m 2m 2m
C4 THERAPEUTICS (CCCC)
NASDAQ
$4.24+$0.12 (+2.79%)
Price as of Jun 23, 2026 6:57 PM EDT- $455.5MMarket Cap
- 180.27%1-Year Change
- BiotechnologyIndustry
C4 THERAPEUTICS (CCCC)
$4.24+$0.12 (+2.79%)
CCCC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.12 | ||
Change | -$0.03 (-0.72%) | ||
Open | $4.17 | ||
High | $4.41 | ||
Low | $4.10 | ||
Previous Close | $4.15 | ||
Volume | 2,995,600 | ||
30-Day Average Volume | 2,491,279 | ||
1-Week Change | 7.85% | ||
1-Month Change | 15.73% | ||
1-Year Change | 180.27% | ||
3-Year Change | 43.06% | ||
5-Year Change | -89.25% | ||
Fundamentals | |||
Shares Outstanding | 110.6M | ||
Total Assets | $328.9M | ||
Market Cap | $455.5M | ||
Enterprise Value | $394.3M | ||
Period: QTR TTM FY | |||
Revenue | $6.2M | ||
Net Income | -$25.1M | ||
Free Cash Flow | -$30.0M | ||
EBIT | -$25.1M | ||
EBITDA | -$24.7M | ||
Net Working Capital | $218.1M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -16 | ||
Enterprise Value/Revenue | 64 | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | 1 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue